One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Donanemab in Early Symptomatic Alzheimer Disease
John R. Sims, MD1; Jennifer A. Zimmer, MD1; Cynthia D. Evans, PhD1; Ming Lu, MD, MS, MPH1; Paul Ardayfio, PhD1; JonDavid Sparks, PhD1; Alette M. Wessels, PhD1; Sergey Shcherbinin, PhD1; Hong Wang, PhD1; Emel Serap Monkul Nery, MD1; Emily C. Collins, PhD1; Paul Solomon, PhD2; Stephen Salloway, MD3,4; Liana G. Apostolova, MD5; Oskar Hansson, MD, PhD6; Craig Ritchie, MD, PhD7; Dawn A. Brooks, PhD1; Mark Mintun, MD1; Daniel M. Skovronsky, MD, PhD1; for the TRAILBLAZER-ALZ 2 Investigators
doi : 10.1001/jama.2023.13239
August 8, 2023, Vol 330, No. 6, Pages 487-574
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction
Tomas G. Neilan, MD, MPH1,2; Thiago Quinaglia, MD, PhD1; Takeshi Onoue, MD3; Syed S. Mahmood, MD, MPH1; Zsofia D. Drobni, MD4; Hannah K. Gilman, BS1; Amanda Smith, MS3; Julius C. Heemelaar, MD1; Priya Brahmbhatt, BS3; Jor Sam Ho, MPH1; Supraja Sama, BS1; Jakub Svoboda, MD5; Donna S. Neuberg, ScD6; Jeremy S. Abramson, MD7; Ephraim P. Hochberg, MD7; Jefferey A. Barnes, MD, PhD7; Philippe Armand, MD8; Eric D. Jacobsen, MD8; Caron A. Jacobson, MD8; Austin I. Kim, MD8; Jacob D. Soumerai, MD7; Yuchi Han, MD3; Robb S. Friedman, MD7; Ann S. Lacasce, MD8; Bonnie Ky, MD3; Dan Landsburg, MD5; Sunita Nasta, MD5; Raymond Y. Kwong, MD9; Michael Jerosch-Herold, PhD10; Robert A. Redd, MS6; Lanqi Hua, MS2,11; James L. Januzzi, MD2,12; Aarti Asnani, MD13; Negareh Mousavi, MD14; Marielle Scherrer-Crosbie, MD, PhD3
doi : 10.1001/jama.2023.11887
Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality
Longgang Zhao, PhD1,2; Xinyuan Zhang, PhD2; Mace Coday, PhD3; David O. Garcia, PhD4; Xinyi Li, PhD5; Yasmin Mossavar-Rahmani, PhD6; Michelle J. Naughton, PhD7; Melissa Lopez-Pentecost, PhD8; Nazmus Saquib, PhD9; Aladdin H. Shadyab, PhD10; Michael S. Simon, MD11,12; Linda G. Snetselaar, PhD13; Fred K. Tabung, PhD14,15,16; Deirdre K. Tobias, ScD16,17; Trang VoPham, PhD18,19; Katherine A. McGlynn, PhD20; Howard D. Sesso, ScD5,16; Edward Giovannucci, ScD5,16; JoAnn E. Manson, MD, DrPH5,17; Frank B. Hu, MD, ScD5,16; Lesley F. Tinker, PhD21; Xuehong Zhang, ScD2,16
doi : 10.1001/jama.2023.12618
Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes
Brian E. McGarry, PT, PhD1; Benjamin D. Sommers, MD, PhD2; Andrew D. Wilcock, PhD3; David C. Grabowski, PhD3; Michael L. Barnett, MD, MS2
doi : 10.1001/jama.2023.12945
Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations
Jessica L. Gleason, PhD, MPH1; Robert Tamburro, MD, MSc2; Caroline Signore, MD, MPH2
doi : 10.1001/jama.2023.10835
Providing Responsible Health Care for Out-of-State Patients
Carmel Shachar, JD, MPH1; Barak D. Richman, JD, PhD2,3; Ateev Mehrotra, MD4
doi : 10.1001/jama.2023.10411
Escaping the Siren Song—Transitioning to Part-Time Work
Ariela L. Marshall, MD1
doi : 10.1001/jama.2023.13214
Ushering in a New Era of Alzheimer Disease Therapy
Eric W. Widera, MD1,2; Sharon A. Brangman, MD3; Nathaniel A. Chin, MD4
doi : 10.1001/jama.2023.11701
Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement Policy
Meredith B. Rosenthal, PhD1
doi : 10.1001/jama.2023.11702
Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease
Gil D. Rabinovici, MD1,2; Renaud La Joie, PhD1
doi : 10.1001/jama.2023.11703
Donanemab for Alzheimer Disease—Who Benefits and Who Is Harmed?
Jennifer J. Manly, PhD1; Kacie D. Deters, PhD2
doi : 10.1001/jama.2023.11704
Cervical Cancer Screening
Rebecca B. Perkins, MD, MSc1; Nicolas Wentzensen, MD, PhD, MS2; Richard S. Guido, MD3,4; Mark Schiffman, MD, MPH2
doi : 10.1001/jama.2023.13174
Diagnosis and Management of Priapism
Richard J. Fantus, MD1; Robert E. Brannigan, MD2; Andrew M. Davis, MD, MPH3
doi : 10.1001/jama.2023.13377
Mounting Evidence Suggests That BMI Isn’t the Only Measure Needed to Predict Mortality Risk
Kate Ruder, MSJ
doi : 10.1001/jama.2023.13602
How the SCOTUS Affirmative Action Ruling Could Affect Medical Schools and Health Care
Rita Rubin, MA
doi : 10.1001/jama.2023.13603
Water and Sanitation Crisis Affects Women and Girls Most
Emily Harris
doi : 10.1001/jama.2023.12552
Study Tests Large Language Models’ Ability to Answer Clinical Questions
Emily Harris
doi : 10.1001/jama.2023.12553
Medical Cannabis Did Not Reduce Pain Prescriptions, Procedures
Emily Harris
doi : 10.1001/jama.2023.12554
Study Helps Explain Racial Disparities in Biological Aging
Emily Harris
doi : 10.1001/jama.2023.12555
Schizophrenia Linked With Genetic Changes That Are Not Inherited
Emily Harris
doi : 10.1001/jama.2023.12556
Implications of Nonhuman “Authors�
Kentaro Matsui, MD, PhD1; Masahide Koda, MD, PhD2; Kazunari Yoshida, MD, PhD3
doi : 10.1001/jama.2023.10568
Implications of Nonhuman “Authors�—Reply
Annette Flanagin, RN, MA1; Kirsten Bibbins-Domingo, PhD, MD, MAS1
doi : 10.1001/jama.2023.10574
